Hematology Diagnostics Market is expected to surpass US$ 2.0 billion by 2033

The Hematology Diagnostics Market is expected to be worth $780.0 million in 2023 and $2.0 billion by 2033. During the forecast period, the market for hematology diagnostics is expected to grow at a CAGR of 9.9%. The increasing chronic diseases such as cancer, blood clots, blood-related disorders, and infections are driving market opportunities. Moreover, growing …

Hand Eczema Treatment Market is expected to grow with a 8% CAGR through 2033

The global Hand Eczema (HE) Treatment Market is predicted to generate a market value of US$ 53 Million in 2023 and a market value of US$ 114.42 Million by 2033, with a CAGR of 8% from 2023 to 2033. In the historical period 2018 to 2022, the market for Hand Eczema (HE) Treatment grew at …

Bispecific Antibody Market is expected to reach US$ 1 billion by 2033, at a CAGR 7.2%

The global bispecific antibody market is expected to reach $500 million by the end of 2023, and $1 billion by 2033, representing a 7.2% CAGR. The bispecific antibody business has benefited greatly from antibody engineering. Much progress has been achieved in generating innovative antibody formats and engineering procedures that allow the creation of bispecific antibodies …

Gastrointestinal Stromal Tumor Therapeutics Market to Register 6% CAGR in 2023 to 2033

During the forecast period 2023 to 2033, the Gastrointestinal Stromal Tumor (GIST) Therapeutics Market is expected to grow at a value of 6% CAGR, according to Future Market Insights. By the year 2033, the global market for Gastrointestinal stromal tumor (GIST) therapeutics is expected to rise up to a market valuation of US$ 1593 Million. …

Monoclonal Gammopathy of Undetermined Significance Management Market to surpass US$ 53.11 million by 2033

The global monoclonal gammopathy of undetermined significance (MGUS) management market is estimated to generate a market value of US$ 27 million in 2023 and a market value of US$ 53.11 million by 2033, growing at a CAGR of 7% from 2023 to 2033. The market for Monoclonal Gammopathy of Undetermined Significance (MGUS) Management grew at …

Pharmaceutical Filtration Market is expected to reach US$ 41.0 Billion by 2032, at a CAGR 8.7% from 2022 to 2032

The global pharmaceutical filtration market is expected to enjoy a valuation of US$ 17.8 Bn by the end of 2022 and further expand at a CAGR of 8.7% to reach a valuation of ~US$ 41.0 Bn by 2032. According to the recent study, membrane filters segment by product is leading the market with a share of about 33.3% in 2021. Active pharmaceutical ingredients are a …

Liquid Biopsy Market to expand at a 13.49% value CAGR by 2032 | FMI projects

The global liquid biopsy market is anticipated to create lucrative growth opportunities over the projection period by exhibiting a total CAGR of 13.49% from 2022 to 2032. The global market is expected to be valued at US$ 1,146 Million in 2022 and surpass a valuation of around US$ 4,126 Million in 2032. The growth of …

Eye Tracking System Market is expected to reach a valuation of US$ 4.9 billion by 2028 | FMI

The global Eye Tracking System Market is anticipated to reach a value of US$ 1.2 billion in 2022 and is projected to close in on US$ 4.9 billion by 2028, growing quickly at a CAGR of 26.6% between 2022 and 2028. Eye-tracking systems are therefore a key amalgamation of software and hardware which allows allowing …

Esophagoscopes & Gastroscopes Market are estimated to attain a valuation of US$ 2.0 billion by 2033

The global Esophagoscopes & Gastroscopes Market currently stands at US$ 1.2 billion and is predicted to exhibit a CAGR of 5.4%. The market is predicted to attain a valuation of US$ 2.0 billion by the end of 2033. Technological Innovations Work in Market’s Favor Innovations in the medical sector have led to a rise in …

Antidepressants to Procure 48% Market Share for Generalized Anxiety Disorder Treatment Market | FMI Study

During the forecast period 2023 to 2033, the Generalized anxiety disorder treatment market is expected to grow at a value of 9% CAGR, according to Future Market Insights. By the year 2033, the global market for Generalized anxiety disorder treatment market is expected to rise up to a market valuation of US$ 4261.25 Million. Growth …